Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
96.76 CHF | -2.32% |
|
-2.17% | +14.45% |
12:43pm | Novartis Q2 Core Earnings, Revenue Advance; 2024 Outlook Updated -- Shares Drop Pre-Bell | MT |
12:21pm | Novartis Lifts Full-Year Guidance on 'Strong Momentum' of Key Growth Drivers | MT |
Sales 2024 * | 49.29B 43.55B 67.42B | Sales 2025 * | 51.41B 45.42B 70.31B | Capitalization | 228B 202B 312B |
---|---|---|---|---|---|
Net income 2024 * | 10.76B 9.51B 14.72B | Net income 2025 * | 12.22B 10.8B 16.72B | EV / Sales 2024 * | 4.9 x |
Net Debt 2024 * | 13.22B 11.68B 18.09B | Net Debt 2025 * | 11.6B 10.25B 15.86B | EV / Sales 2025 * | 4.67 x |
P/E ratio 2024 * |
21.7
x | P/E ratio 2025 * |
18.8
x | Employees | 76,057 |
Yield 2024 * |
3.31% | Yield 2025 * |
3.43% | Free-Float | 85.22% |
Latest transcript on Novartis AG
1 day | -2.32% | ||
1 week | -2.17% | ||
Current month | +1.00% | ||
1 month | +4.27% | ||
3 months | +14.92% | ||
6 months | +4.31% | ||
Current year | +14.45% |
![Extreme 96.03](/images/extremecours_fleche.png)
![Extreme 92.8](/images/extremecours_fleche.png)
![Extreme 83.63](/images/extremecours_fleche.png)
![Extreme 83](/images/extremecours_fleche.png)
![Extreme 72.84](/images/extremecours_fleche.png)
![Extreme 65.09](/images/extremecours_fleche.png)
![Extreme 65.09](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.40% | 121 M€ | -.--% | - | |
5.57% | 14 M€ | +11.35% | - | |
4.12% | 88 M€ | +10.37% | - | |
3.79% | 2 M€ | -25.75% |
Date | Price | Change | Volume |
---|---|---|---|
24-07-18 | 97.01 | -2.07% | 1 325 780 |
24-07-17 | 99.06 | +0.16% | 3,512,848 |
24-07-16 | 98.9 | -0.20% | 2,133,566 |
24-07-15 | 99.1 | -0.96% | 2,183,223 |
24-07-12 | 100.1 | +0.79% | 2,652,925 |
Delayed Quote Swiss Exchange, July 18, 2024 at 07:01 am
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.45% | 228B | |
+55.35% | 815B | |
+32.43% | 597B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+16.26% | 247B | |
+16.54% | 180B | |
+4.31% | 170B | |
+2.87% | 126B |
- Stock Market
- Equities
- NOVN Stock